Clinical Trial

SODium BICarbonate for Metabolic Acidosis in the ICU

Study acronym: SODa-BIC
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This trial aims to assess if, among adults in the ICU with metabolic acidosis, an infusion of sodium bicarbonate diluted in 5% dextrose, compared with an infusion of 5% dextrose, reduces Major Adverse Kidney Events within 30 days of randomization.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-01-15; most recent amendment 2026-03-23.
Status change: Recruiting → Active, Not Recruiting 2026-01-04
Status change: Not Yet Recruiting → Recruiting 2023-04-18
Trial Details
NCT Number NCT05697770
Lead Sponsor Australian and New Zealand Intensive Care Research Centre
Conditions Metabolic Acidosis, Shock
Enrollment 500 participants
Start Date 2023-04-26
Primary Completion 2026-01-08 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-03-27